Fig. 4

Relative magnitude of placebo effect. Population-level estimates of placebo effect for different clinical metrics. Percentage improvement of disease state from PBO treatment relative to BL (dark bars) and magnitude of PBO effect relative to magnitude of GOL effect (light bars). BL baseline disease state, DAS Disease Activity Score, GOL golimumab, lCRP log transform of C-reactive protein metric, PBO placebo, rSJC square root of SJC, rTJC square root of TJC, SJC swollen joint count, TJC tender joint count